Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Leiomyosarcoma × durvalumab × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 42 Lung Neoplasms 21 Carcinoma, Hepatocellular 16 Breast Neoplasms 16 Small Cell Lung Carcinoma 11 Urinary Bladder Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 7 Neoplasm Metastasis 7 Liver Neoplasms 7 Triple Negative Breast Neoplasms 5 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Neoplasms 5 Cholangiocarcinoma 5 Carcinoma 5 Biliary Tract Neoplasms 5 Stomach Neoplasms 4 Melanoma 4 Endometrial Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Squamous Cell 4 Carcinoma, Renal Cell 4 Prostatic Neoplasms 3 Neoplasms by Site 3 Gallbladder Neoplasms 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Turcot syndrome 2 Thyroid Neoplasms 2

Interventions

Radiotherapy 3 Radiation 3 pazopanib 2 Nivolumab 2 Doxorubicin 2 talimogene laherparepvec 1 sotigalimab 1 rucaparib 1 ribociclib 1 olaparib 1 futibatinib 1 durvalumab 1 cediranib 1 cabozantinib 1 Temozolomide 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 Gemcitabine 1 Everolimus 1 Erlotinib Hydrochloride 1 Biopsy 1 BO-112 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03851614 2026-02-09

DAPPER

University Health Network, Toronto

Phase 2 Active not recruiting

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡